In a precedential decision, the Federal Circuit ruled that three of four asserted trade secrets relating to the Penuma cosmetic implant were generally known because they had been disclosed in publicly available patents, while affirming a $1 million trademark counterfeiting award based on the defendant's unauthorized advertising of the Penuma mark.
